148 related articles for article (PubMed ID: 21466675)
1. Exploring the link between MORF4L1 and risk of breast cancer.
Martrat G; Maxwell CM; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gómez-Baldó L; Bogliolo M; Lázaro C; Blanco I; Brunet J; Aguilar H; Fernández-Rodríguez J; Seal S; Renwick A; Rahman N; Kühl J; Neveling K; Schindler D; Ramírez MJ; Castellà M; Hernández G; ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong KR; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; ; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MG; van Os TA; Blok MJ; Meijers-Heijboer HE; Hogervorst FB; ; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; ; ; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldés T; Osorio A; Benítez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon YJ; Uhrhammer N; Peyrat JP; Vennin P; Ferrer SF; Collonge-Rame MA; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Cerón J; Tominaga K; Surrallés J; Pujana MA
Breast Cancer Res; 2011 Apr; 13(2):R40. PubMed ID: 21466675
[TBL] [Abstract][Full Text] [Related]
2. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk.
Ricks-Santi LJ; Sucheston LE; Yang Y; Freudenheim JL; Isaacs CJ; Schwartz MD; Dumitrescu RG; Marian C; Nie J; Vito D; Edge SB; Shields PG
BMC Cancer; 2011 Jun; 11():278. PubMed ID: 21708019
[TBL] [Abstract][Full Text] [Related]
3. Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.
Buisson R; Dion-Côté AM; Coulombe Y; Launay H; Cai H; Stasiak AZ; Stasiak A; Xia B; Masson JY
Nat Struct Mol Biol; 2010 Oct; 17(10):1247-54. PubMed ID: 20871615
[TBL] [Abstract][Full Text] [Related]
4. Fanconi anemia-associated mutation in RAD51 compromises the coordinated action of DNA-binding and ATPase activities.
Liu S; Shinohara A; Furukohri A
J Biol Chem; 2023 Dec; 299(12):105424. PubMed ID: 37924868
[TBL] [Abstract][Full Text] [Related]
5. Two truncating variants in FANCC and breast cancer risk.
Dörk T; Peterlongo P; Mannermaa A; Bolla MK; Wang Q; Dennis J; Ahearn T; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Augustinsson A; Freeman LEB; Beckmann MW; Beeghly-Fadiel A; Behrens S; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Burwinkel B; Canzian F; Chan TL; Chang-Claude J; Chanock SJ; Choi JY; Christiansen H; Clarke CL; Couch FJ; Czene K; Daly MB; Dos-Santos-Silva I; Dwek M; Eccles DM; Ekici AB; Eriksson M; Evans DG; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; Gao C; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haeberle L; Haiman CA; Håkansson N; Hall P; Hamann U; Hartman M; Hauke J; Hein A; Hillemanns P; Hogervorst FBL; Hooning MJ; Hopper JL; Howell T; Huo D; Ito H; Iwasaki M; Jakubowska A; Janni W; John EM; Jung A; Kaaks R; Kang D; Kapoor PM; Khusnutdinova E; Kim SW; Kitahara CM; Koutros S; Kraft P; Kristensen VN; Kwong A; Lambrechts D; Marchand LL; Li J; Lindström S; Linet M; Lo WY; Long J; Lophatananon A; Lubiński J; Manoochehri M; Manoukian S; Margolin S; Martinez E; Matsuo K; Mavroudis D; Meindl A; Menon U; Milne RL; Mohd Taib NA; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Neven P; Newman WG; Offit K; Olopade OI; Olshan AF; Olson JE; Olsson H; Park SK; Park-Simon TW; Peto J; Plaseska-Karanfilska D; Pohl-Rescigno E; Presneau N; Rack B; Radice P; Rashid MU; Rennert G; Rennert HS; Romero A; Ruebner M; Saloustros E; Schmidt MK; Schmutzler RK; Schneider MO; Schoemaker MJ; Scott C; Shen CY; Shu XO; Simard J; Slager S; Smichkoska S; Southey MC; Spinelli JJ; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Toland AE; Tollenaar RAEM; Torres D; Torres-Mejía G; Troester MA; Truong T; Tsugane S; Untch M; Vachon CM; Ouweland AMWVD; Veen EMV; Vijai J; Wendt C; Wolk A; Yu JC; Zheng W; Ziogas A; Ziv E; ; ; Dunning AM; Pharoah PDP; Schindler D; Devilee P; Easton DF
Sci Rep; 2019 Aug; 9(1):12524. PubMed ID: 31467304
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.
Cheung RS; Taniguchi T
Int J Hematol; 2017 Sep; 106(3):335-344. PubMed ID: 28631178
[TBL] [Abstract][Full Text] [Related]
7. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract][Full Text] [Related]
8. Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure.
Kreutmair S; Erlacher M; Andrieux G; Istvanffy R; Mueller-Rudorf A; Zwick M; Rückert T; Pantic M; Poggio T; Shoumariyeh K; Mueller TA; Kawaguchi H; Follo M; Klingeberg C; Wlodarski M; Baumann I; Pfeifer D; Kulinski M; Rudelius M; Lemeer S; Kuster B; Dierks C; Peschel C; Cabezas-Wallscheid N; Duque-Afonso J; Zeiser R; Cleary ML; Schindler D; Schmitt-Graeff A; Boerries M; Niemeyer CM; Oostendorp RA; Duyster J; Illert AL
J Clin Invest; 2020 Jun; 130(6):2827-2844. PubMed ID: 32338640
[TBL] [Abstract][Full Text] [Related]
9. Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress.
Tomaszowski KH; Roy S; Guerrero C; Shukla P; Keshvani C; Chen Y; Ott M; Wu X; Zhang J; DiNardo CD; Schindler D; Schlacher K
Nat Commun; 2023 Mar; 14(1):1333. PubMed ID: 36906610
[TBL] [Abstract][Full Text] [Related]
10. PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling.
Tuppurainen H; Laurila N; Nätynki M; Eshraghi L; Tervasmäki A; Erichsen L; Sørensen CS; Pylkäs K; Winqvist R; Peltoketo H
Cell Mol Life Sci; 2024 Apr; 81(1):173. PubMed ID: 38597967
[TBL] [Abstract][Full Text] [Related]
11. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays.
Sadeghi F; Asgari M; Matloubi M; Ranjbar M; Karkhaneh Yousefi N; Azari T; Zaki-Dizaji M
Biol Proced Online; 2020; 22():23. PubMed ID: 33013205
[TBL] [Abstract][Full Text] [Related]
12. MrgX is not essential for cell growth and development in the mouse.
Tominaga K; Matzuk MM; Pereira-Smith OM
Mol Cell Biol; 2005 Jun; 25(12):4873-80. PubMed ID: 15923606
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
Berwick M; Satagopan JM; Ben-Porat L; Carlson A; Mah K; Henry R; Diotti R; Milton K; Pujara K; Landers T; Dev Batish S; Morales J; Schindler D; Hanenberg H; Hromas R; Levran O; Auerbach AD
Cancer Res; 2007 Oct; 67(19):9591-6. PubMed ID: 17909071
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in early onset luminal breast cancer.
Encinas G; Sabelnykova VY; de Lyra EC; Hirata Katayama ML; Maistro S; de Vasconcellos Valle PWM; de Lima Pereira GF; Rodrigues LM; de Menezes Pacheco Serio PA; de Gouvêa ACRC; Geyer FC; Basso RA; Pasini FS; Del Pilar Esteves Diz M; Brentani MM; Guedes Sampaio Góes JC; Chammas R; Boutros PC; Koike Folgueira MAA
Oncotarget; 2018 Apr; 9(32):22460-22479. PubMed ID: 29854292
[TBL] [Abstract][Full Text] [Related]
15. Identification of potentially oncogenic alterations from tumor-only samples reveals Fanconi anemia pathway mutations in bladder carcinomas.
Madubata CJ; Roshan-Ghias A; Chu T; Resnick S; Zhao J; Arnes L; Wang J; Rabadan R
NPJ Genom Med; 2017; 2():29. PubMed ID: 29263839
[TBL] [Abstract][Full Text] [Related]
16. Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer.
Edogbanya J; Tejada-Martinez D; Jones NJ; Jaiswal A; Bell S; Cordeiro R; van Dam S; Rigden DJ; de Magalhães JP
Cell Mol Life Sci; 2021 May; 78(9):4365-4376. PubMed ID: 33625522
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional insights into the epigenetic regulator MRG15.
Jiang N; Li YB; Jin JY; Guo JY; Ding QR; Meng D; Zhi XL
Acta Pharmacol Sin; 2024 May; 45(5):879-889. PubMed ID: 38191914
[TBL] [Abstract][Full Text] [Related]
18. Genetic Testing for Breast Cancer in the Era of Multigene Panels: Can We Make an Impact on Population Health?
Ginsburg O; Brennan P
J Clin Oncol; 2018 Oct; 36(28):2817-2819. PubMed ID: 30130156
[No Abstract] [Full Text] [Related]
19. DNA damage, obesity and obesity-related health complications: what are new data telling us?
Włodarczyk M; Nowicka G
Curr Opin Clin Nutr Metab Care; 2024 Apr; ():. PubMed ID: 38652557
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of MRG15 in liver metabolic diseases.
Tian C; Gu X; Jiang C; Ding Q
Trends Mol Med; 2024 Mar; ():. PubMed ID: 38521716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
